1. Inserm Unité Mixte de Recherche (UMR) 866, Faculté de Médecine, Dijon, France;
2. University of Burgundy, Dijon, France;
3. École Pratique des Hautes Études, Laboratoire d'Immunologie et Immunothérapie des cancers, Dijon, France;
4. Curie Institute, Paris, France;
5. Department for Molecular Biomedical Research, Unit for Molecular Signalling and Cell Death, VIB (Flanders Institute for Biotechnology), Ghent, Belgium;
6. Department of Biomedical Molecular Biology, Unit for Molecular Signalling and Cell Death, Ghent University, Ghent, Belgium;
7. Inserm UMR 1009, Institut Gustave Roussy, Villejuif, France; and
8. Université Paris-Sud 11, Paris, France